Nath Bio-Genes (India) Ltd - 537291 - Update To Shareholders On COVID-19
Update to Shareholders on COVID-1904-05-2020
04-05-2020
Nath Bio-Genes (India) Ltd - 537291 - Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- DHIRAJ RATHIDesignation :- Company Secretary and Compliance Officer30-04-2020
Nath Bio-Genes (India) Ltd - 537291 - Announcement For Introduction Of New Cotton Hybrids.
Announcement for Introduction of New Cotton Hybrids.28-04-2020
Nath Bio-Genes (India) Ltd - 537291 - Shareholding for the Period Ended March 31, 2020
Nath Bio-Genes (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click here28-04-2020
Nath Bio-Genes (India) Ltd - 537291 - Compliance Certificate Under Regulation 7(3) For The Financial Year Ended 31St March 2020.
Compliance Certificate under Regulation 7(3) for the financial year ended 31st March 2020.25-04-2020
Nath Bio-Genes (India) Ltd - 537291 - Intimation About Conference Call Held
Intimation about Conference call held21-04-2020
Nath Bio-Genes (India) Ltd - 537291 - Clarification
With reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded, Nath Bio-Genes (India) Ltd has submitted to BSE a copy of Clarification is enclosed.20-04-2020
Nath Bio-Genes (India) Ltd - 537291 - Recommencement Of Operational Activities Of The Company.
Recommencement of Operational Activities of the Company.17-04-2020
Nath Bio-Genes (India) Ltd - 537291 - Clarification sought from Nath Bio-Genes (India) Ltd
The Exchange has sought clarification from Nath Bio-Genes (India) Ltd on April 15th , 2020 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.15-04-2020
Nath Bio-Genes (India) Ltd - 537291 - Closure of Trading Window
Closure of Trading Window31-03-2020